Healthcare -
Biotechnology - NASDAQ - US
$ 7.12
-1.93 %
$ 260 M
Market Cap
-2.27
P/E
Price Target
Average
429.03%
Revenue Forecast
Estimate
92.50%
EBIT
Estimate
31.48%
Net Income
Estimate
10.21%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
iTeos Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ITOS of $37.7 , with forecasts ranging from
a
low of
$31 to a high of $46 .
ITOS Lowest Price Target
Wall Street Target
31 USD
335.39%
ITOS Average Price Target
Wall Street Target
37.7 USD
429.03%
ITOS Highest Price Target
Wall Street Target
46 USD
546.07%
REVENUE FORECAST
Revenue Forecast Chart ITOS
EBIT FORECAST
EBIT Forecast Chart ITOS
NET INCOME FORECAST
Net Income Chart ITOS